Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Acquisition

30 Mar 2012 07:00

Anpario plc ("Anpario", the "Company" or the "Group")

Acquisition of Meriden Animal Health Limited

Highlights

Acquisition of Meriden Animal Health Limited ("Meriden") for up to £4.125 million Meriden's 2011 sales and adjusted profit before interest and tax were £5.35 million and £740,000 respectively Expected to be immediately earnings enhancing Deal increases Anpario's global market share and significantly strengthens its position in China Consideration to be met from the Company's existing cash resources

Anpario plc, one of the leading suppliers of natural high performance feed additives to enhance health, growth and sustainability in global agriculture and aquaculture markets, is pleased to announce the acquisition of Meriden Animal Health Limited for a total consideration of up to £4.125 million.

The acquisition of Meriden brings another strong trading brand to the Anpario Group, broadening its product technology and increasing Anpario's global market share in the feed additive sector.

Meriden based in Bedfordshire in the United Kingdom, supplies the global agriculture and aquaculture markets with natural animal feed additive products. Meriden's Orego-Stim range of products, using essential oils, is the leading brand in its field and is marketed across 60 countries worldwide, with the majority of sales being outside the United Kingdom

Meriden's sales for the 12 months to December 2011 were £5.35 million and adjusted profit before interest and tax was £740,000. Net assets acquired will be at least £1.644 million, the majority being working capital, including cash in excess of £400,000. The acquisition is expected to be immediately earnings enhancing to the Group as a whole.

Meriden has ten full time staff including a technical support team based in a representative office in Malaysia. The majority of production is outsourced to a third party manufacturer based in the United Kingdom. Meriden typically supplies through distributors in the local territories except Australia where the company has a joint venture company.

Meriden has a close and important partnership with its China operation with sales accounting for 26% of Meriden's total sales during 2011. The China business has been growing well and Anpario intends to give further support to this relationship to capitalise on the vast potential of China's agriculture market.

In line with Anpario's strategy, Meriden will be run as a separate business enabling the team to focus on selling and marketing high quality feed additive products around the world. Joining Anpario means Meriden's management team will gain additional support and can benefit from working together with Anpario's research and development resource to develop new and innovative products for sale under the Meriden brand.

The two shareholders and founders, namely, Stephen Harris, Managing Director, and Pamela McLaren, Company Secretary, are to remain with the business in their existing roles and will continue to develop the Meriden business further.

The price payable for Meriden is on a debt free basis but will include estimated excess cash of £400,000. An initial payment of £3.0 million in cash on completion has been made from existing cash resources. The remaining £1.125 million is payable over the next two years, dependent on Meriden achieving certain performance criteria, and of this, £125,000 is to be satisfied by the issue of ordinary shares of Anpario to Meriden's shareholders. Subsequent to the completion of this acquisition, Anpario's cash balances will be in excess of £2.5 million.

The Company expects to announce its results for the year ended 31 December 2011 on 26 April 2012.

Richard Edwards, Executive Vice Chairman of Anpario, commented:

"Meriden Animal Health is a quality business with strong brand recognition for developing 100% natural feed additives. This acquisition increases our global market share in animal feed additives which is benefiting as the agriculture industry looks to use natural based solutions to promote the health and growth of animals for meat consumption.

Meriden's significant presence in China increases our involvement in the world's biggest producer of poultry and pig meat and reinforces our strategy to build more significant positions in emerging agriculture and aquaculture markets. We are delighted to welcome the Meriden team and very much look forward to working with them in achieving continued success with the business."

Enquiries:

Anpario plcRichard Edwards, Executive Vice Chairman +44 (0)7776 417129Karen Prior, Group Finance Director +44 (0)1909 537380

FinnCap +44 (0)20 7600 1658Matthew Robinson / Henrik Persson - Corporate FinanceStephen Norcross - Corporate Broking

Copyright Business Wire 2012

Date   Source Headline
30th Jan 20207:00 amBUSTrading Statement
20th Jan 202010:05 amRNSHolding(s) in Company
17th Jan 20204:55 pmRNSBlock listing Interim Review
17th Jan 20209:40 amRNSHolding(s) in Company
13th Jan 202010:31 amRNSHolding(s) in Company
8th Jan 20203:39 pmRNSHolding(s) in Company
6th Jan 202011:04 amRNSHolding(s) in Company
18th Nov 20195:30 pmRNSHolding(s) in Company
5th Nov 20199:44 amRNSHolding(s) in Company
11th Sep 20197:00 amBUSHalf-year Report
14th Aug 201911:10 amRNSHolding(s) in Company
13th Aug 20196:08 pmRNSHolding(s) in Company
17th Jul 201910:41 amRNSBlock listing Interim Review
27th Jun 20194:23 pmRNSResult of AGM
27th Jun 20197:00 amRNSAGM Statement
21st Jun 20197:00 amRNSTotal Voting Rights
5th Jun 201910:47 amRNSDirector/PDMR Shareholding
4th Jun 20195:35 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:27 pmRNSHolding(s) in Company
17th Apr 20192:04 pmRNSHolding(s) in Company
2nd Apr 201910:33 amRNSTotal Voting Rights
8th Mar 201911:06 amRNSFinal Results
6th Mar 20197:00 amBUSFinal Results
5th Mar 20194:17 pmRNSTotal Voting Rights
29th Jan 20197:00 amRNSPre-Close Trading Statement
17th Jan 201912:17 pmRNSBlock listing Interim Review
6th Dec 20182:30 pmRNSHolding(s) in Company
6th Dec 20182:25 pmRNSHolding(s) in Company
2nd Oct 20183:51 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSHalf-year Report
31st Jul 20189:54 amRNSHolding(s) in Company
19th Jul 20183:30 pmRNSBlock listing Interim Review
28th Jun 20184:05 pmBUSResult of AGM
28th Jun 20187:00 amRNSAGM Statement
5th Jun 20183:58 pmRNSAnnual Report and Notice of AGM
4th Jun 20183:17 pmRNSTotal Voting Rights
4th May 201812:05 pmRNSTotal Voting Rights
9th Apr 20188:25 amRNSTotal Voting Rights
7th Mar 20187:00 amBUSFinal Results
5th Mar 20183:16 pmRNSHolding(s) in Company
5th Feb 20182:21 pmRNSTotal Voting Rights
29th Jan 20187:00 amRNSTrading Statement
19th Jan 20182:32 pmRNSBlock listing Six Monthly Return
22nd Nov 20174:53 pmRNSEmployee Share Plan and Directors' Dealing
20th Oct 20177:00 amRNSDirectorate Change
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
21st Sep 20173:30 pmRNSDirector/PDMR Shareholding
19th Sep 20177:00 amBUSHalf-year Report
28th Jul 20179:46 amRNSBlock Listing Return
18th Jul 20174:58 pmRNSDirector/PDMR Shareholding and Issue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.